Sort   by:  
 Page size 
UnknownSubcutaneous administration of rituximab (MabThera) and trastuzumab (Herceptin) using hyaluronidase.
Not available
S-EPMC3776971 | biostudies-literature
UnknownNetwork analysis of microRNAs, genes and their regulation in diffuse and follicular B-cell lymphomas.
Not available
S-EPMC5814270 | biostudies-literature
UnknownBortezomib, thalidomide and dexamethasone, with or without cyclophosphamide, for patients with previously untreated multiple myeloma: 5-year follow-up.
Not available
S-EPMC4758383 | biostudies-literature
UnknownBendamustine for patients with indolent B cell lymphoid malignancies including chronic lymphocytic leukaemia.
Not available
S-EPMC7387870 | biostudies-literature
UnknownRituximab maintenance therapy after autologous stem-cell transplantation in patients with relapsed CD20(+) diffuse large B-cell lymphoma: final analysis of the collaborative trial in relapsed aggressive lymphoma.
Not available
S-EPMC3646314 | biostudies-literature
UnknownAL amyloidosis clonal plasma cells are regulated by microRNAs and dependent on anti-apoptotic BCL2 family members.
Not available
S-EPMC10134277 | biostudies-literature
UnknownNovel dual action chimera doxorubizen demonstrates superior efficacy to doxorubicin in acute leukemia.
Not available
S-EPMC11950436 | biostudies-literature
UnknownMicroRNA-15a-5p acts as a tumor suppressor in histiocytosis by mediating CXCL10-ERK-LIN28a-let-7 axis.
Not available
S-EPMC8979810 | biostudies-literature
UnknownHigh-dose vincristine sulfate liposome injection for advanced, relapsed, and refractory adult Philadelphia chromosome-negative acute lymphoblastic leukemia.
Not available
S-EPMC4979201 | biostudies-literature
UnknownMutant PIK3CA is a targetable driver alteration in histiocytic neoplasms.
Not available
S-EPMC10711187 | biostudies-literature
Sort   by:  
 Page size